The nation of Zimbabwe has turned down a major US health deal worth 367 million US dollars (£272m) over five years over Washington's demand for sensitive data.
This move became public after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman has since explained that the United States was demanding access to health data for research and commercial gain but was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued dialogue to secure a agreement agreeable to all parties so the country's vital HIV treatment initiative can continue.
Wider Background
This rejection comes after a similar case in neighbouring Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government deals to boost transparency and accountability.
As per statements, Sixteen African countries have so far signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to share its biological resources and data indefinitely, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our citizens if a new disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously set up via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This framework is intended to guarantee that when a country provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a manner that respects the independence and dignity of each country."
Medical Community Reaction
A leading public health body stated it understood the official position, but recommended that negotiations must proceed given that much of the country's Aids initiatives were funded by external financing.
"If technical issues arise, including those relating to information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.
This impasse underscores the complex challenges between accepting crucial foreign assistance and protecting local interests in an increasingly interconnected world.